Drug Profile
Melanotan II
Alternative Names: MT II; PT-14Latest Information Update: 22 Sep 2003
Price :
$50
*
At a glance
- Originator University of Arizona
- Class Erectile dysfunction therapies; Peptide hormones
- Mechanism of Action Melanocortin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction; Male sexual dysfunction
Most Recent Events
- 22 Sep 2003 Discontinued - Phase-II for Erectile dysfunction in USA (Injection)
- 22 Sep 2003 Discontinued - Phase-II for Male sexual dysfunction in USA (Injection)
- 08 Mar 2002 Discontinued - Preclinical for Erectile dysfunction in USA (Transmucosal)